Erin Catherine Carter

Insider Reports History

Location
Rutherford, NJ
Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erin Catherine Carter:

Company Role Class Num Shares Value Price $ Report Date Ownership
Glucotrack, Inc. Director Common Stock, par value $0.001 per share 2,148 $10,460 $4.87 03 Oct 2025 Direct
Glucotrack, Inc. Director Stock option (right to buy) 4,055 03 Oct 2025 Direct
Glucotrack, Inc. Director Series A Common Warrant 2,078 14 Nov 2024 Direct
Glucotrack, Inc. Director Convertible Promissory Note 0 14 Nov 2024 Direct
Glucotrack, Inc. Director Series B Common Warrant 0 12 Mar 2025 Direct

Insider Reports Filed by Erin Catherine Carter

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GCTK Glucotrack, Inc. 25 Mar 2025 4 $0 4 Director 07 Oct 2025, 20:58
GCTK Glucotrack, Inc. 31 Dec 2023 10 +$179,665 4 Director 31 Mar 2025, 07:52
GCTK GlucoTrack, Inc. 25 Aug 2023 0 $0 3 Director 11 Sep 2023, 20:43